Jakob M. Goldmann

technology development for virus metagenomics

Jakob is developing technology for next-generation virus discovery, currently at Merck, Sharpe and Dohme. He has been analyzing DNA sequencing data since 2012 and obtained a PhD in computational human genomics. He did research on de novo mutations and wrote scientific publications about germline biology. He coordinates projects in international, multi-disciplinary teams.